Training, certification, and reimbursement for nephrology procedures

Seminars in Nephrology

Volumn 22, Issue 3, 2002, Pages 276-285

  Saad, Theodore F ^a  

^a Nephrology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; CERTIFICATION; CLINICAL PRACTICE; COST CONTROL; HEALTH CARE COST; HEMODIALYSIS; KIDNEY FAILURE; MEDICAL CARE; MEDICAL EDUCATION; MEDICAL SPECIALIST; NEPHROLOGY; PATIENT CARE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW; VASCULAR ACCESS;

EID: 0036096160     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1053/snep.2002.31715     Document Type: Review

References (22)

1. Creating a dedicated vascular access center within a nephrology practice
2. Interventional care of the hemodialysis patient: It's about quality
3. The new nephrologist
4. Hemodialysis vascular access morbidity
5. Improving access patency: Pre-end-stage renal disease strategies
6. Emergence of interventional nephrology as a new subspecialty
7. Training standards for physicians performing peripheral angioplasty and other percutaneous peripheral vascular interventions
8. Revised guidelines for the performance of peripheral vascular intervention
9. Credentials for peripheral angioplasty: Comments on Society of cardiac angiography and intervention revisions
10. Quality improvement guidelines for percutaneous management of the thrombosed or dysfunctional dialysis access
11. Reporting standards for percutaneous interventions in dialysis access
12. NKF-K/DOQI: Clinical practice guidelines for vascular access: Update 2000
13. Tunneled-cuffed venous hemodialysis catheter insertion with or without use of fluoroscopy
14. Comparison of transposed brachiobasilic fistulas to upper arm grafts and brachiocephalic fistulas
15. Vascular access survival and incidence of revisions: A comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study
16. Development of an end-stage renal disease managed care demonstration